This important study describes a first-in-human trial of autologous p63+ stem cells in patients with idiopathic pulmonary fibrosis, a lethal condition for which effective treatments are lacking. The ...

A 32-year-old Australian woman’s seemingly harmless pimple on the forehead was eventually diagnosed as skin cancer when it ...

MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...

Eight weeks after completion of the therapy, 11 lesions (55%) clinically showed complete remission, six lesions (30%) showed partial remission, and two lesions (10%) showed no response.

The aim of our study was to evaluate the efficacy and long-term results of interferon a-2a (IFNa-2a) in the treatment of basal cell carcinoma. Results: Eleven lesions (55%) showed complete ...

This image provided by Ana-Maria Cujba shows blood vessels in a portion of the human small intestine, March 21, 2024. (Ana-Maria Cujba/Wellcome Sanger Institute via AP) This image provided by Nathan ...

They surround the tumor nests and may prevent immune cells ... iCAFs are increasingly found in aggressive forms of skin cancer (invasive basal cell carcinoma and high-grade melanoma).

They surround the tumor nests and may prevent immune cells ... iCAFs are increasingly found in aggressive forms of skin cancer (invasive basal cell carcinoma and high-grade melanoma).

Basal cell carcinoma (BCC) is the most common type of skin cancer worldwide, often producing shiny lesions on the skin that can be (but are not always) discolored. It develops in the basal cells, ...

Emrosi is expected to be available in the first quarter or early second quarter of 2025. The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) ...